In this study, the inhibitory action of angiotensin II (Ang II) receptor blocker (ARB) on Ang II-induced conduction blocking in the left atrium was studied. Transmembrane action potentials and effective refractory period (ERP) were recorded from the left atrial trabeculae of spontaneously hypertensive rats (SHR Izm s) that had been treated with or without olmesartan medoxomil (AT1 receptor blocker, 3.0 mg kg À1 ) for 8 weeks before the recording. During rapid electrical stimulation (RES), changes in activation time (AT) and frequencies of the conduction block were studied under perfusion of Ang II (10 À8 M) or Ang II plus ARB (10 À7 M). Interstitial fibrosis in the left atrium was quantitatively assessed using histological sections. Although action potential parameters and ERP did not differ between the two groups when preparations were driven with a basic cycle length, an Ang II-induced conduction delay was observed during RES, and this was significantly suppressed in SHR Izm s treated with ARB (Po0.05). The Ang II-induced conduction block was also significantly reduced with perfusion of ARB (Po0.05). The interstitial fibrous area was significantly larger in untreated SHR Izm s than in treated animals (Po0.01). This antagonizing action of AT1 blockade might contribute to its non-antiarrhythmic therapeutic effect on atrial fibrillation because of its indirect and direct actions on the structural and functional remodeling of the left atrium.
INTRODUCTION
Recent meta-analyses have shown that an angiotensin-converting enzyme inhibitor and an angiotensin II (Ang II) receptor blocker (ARB) are both effective at preventing new and recurrent atrial fibrillation (AF). 1,2 A plausible pathophysiological mechanism for AF prevention may be the indirect antiarrhythmic actions of these drugs, including reverse atrial remodeling, attenuation of left atrial (LA) stretch and inflammation. [2] [3] [4] [5] However, the cellular electrophysiological actions induced by these drugs in normal LA tissue and LA tissue remodeled because of spontaneous hypertension are not known. If Ang II blockade is beneficial for AF prevention, as shown in clinical studies, any direct cellular electrophysiological actions induced by these drugs in LA tissue should be examined. Therefore, in this study, LA preparations from spontaneously hypertensive rats (SHR Izm s) were dissected. Transmembrane action potentials and activation times (ATs) were measured during rapid electrical stimulation (RES). Using this model, the actions of Ang II on impulse propagation through LA trabeculae were evaluated in male adult SHR Izm s treated with and without the ARB, olmesartan.
METHODS

Animals and preparations
Adult male SHR Izm s (n¼24), obtained from the Disease Model Cooperation Research Association (Tokyo, Japan), were used to investigate remodelingassociated electrophysiological changes. To evaluate the effects of reverse remodeling, an Ang II type 1 receptor blocker (AT1 blocker; olmesartan medoxomil 3.0 mg kg À1 per day; Daiichi Sankyo Co. Ltd, Tokyo, Japan) was orally administered (n¼12) for 8 weeks from 14 to 22 weeks of age. 6 Experimental procedures were conducted in accordance with the National Institutes of Health guidelines, and were approved by the Showa University Institutional Animal Care and Use Committee.
After body weight and systolic arterial blood pressure (using the tail-cuff method) were measured, each rat was anesthetized with sodium pentobarbital (50 mg kg À1 , intra-peritoneal injection), and its heart was quickly removed. The left atrium with the atrial septum was dissected from the mitral orifice. The preparation was mounted in a lucite superfusion chamber in which the effective volume was 2.5 ml. The LA preparation was attached by its epicardial surface to the bottom of the chamber.
The LA endocardial surface could be seen when the cut edges were pinned ( Figure 1a) . The preparations were superfused with oxygenated normal Tyrode solution (3 ml min À1 ) bubbled with 97% O 2 and 3% CO 2 at a temperature of 37 ± 0.2 1C. The composition of the Tyrode solution was as follows (mM): NaCl 137.0; NaH 2 PO 4 1.8; NaHCO 3 12.0; MgCl 2 0.5; KCl 5.4; CaCl 2 1.8; glucose 5.5; pH adjusted to 7.2-7.3. Equilibration was allowed for at least 30 min to obtain stable recordings.
The preparation was driven by electrical current stimulation at 2 Hz applied at the end of the LA preparation near the mitral orifice. The intensity of the current pulse was twice that of the threshold, and the pulse duration was 2 ms. The pulses were delivered to the preparation with modified bipolar electrodes ( Figure 1c ). To pass flat-shaped excitation fronts through the surface of the trabecula, modified bipolar electrodes were used. The expanded tip of a modified concentric circle bipolar electrode is illustrated in the square inset of Figure 1c . When the internal core of this electrode is charged and the cathode contacts the surface of the specimen, the impulse propagation stabilizes and AT can be measured even from small specimens like rat LA trabeculae. AT was defined as the interval from the stimulation artifact to the peak of dV/dt max . To measure transmembrane action potential and AT, glass microelectrodes filled with 3 M KCl and with a tip resistance of 20 ± 5 MO were used. These were connected to a high-impedance DC amplifier with input capacity neutralization (MEZ 3000; Nihon Kohden Co. Ltd, Tokyo, Japan). As shown in Figure 1c , one microelectrode (E 1 ) was embedded in a myocardial cell 3 mm away from the stimulation site. The action potential was recorded as the voltage difference between the recording microelectrode and the other neutral microelectrode, which was placed in the perfusate as close as possible to the recording microelectrode (E 2 ). The effective refractory period (ERP) was measured as the minimum coupling interval eliciting a conductive action potential by premature stimulation applied to the preparations every eight basic stimuli. The action potential and the maximum upstroke velocity of the action potential (dV/dt max ) were displayed on the oscilloscope screen and captured as animations (frame rate, 33 s À1 ) with a DVD recorder (DZ-MV580 WOOO; Hitachi Co. Ltd, Tokyo, Japan) or photographed with a polaroid camera (Figure 1b) . At the same time, these signals were simultaneously recorded on a strip chart using photosensitive paper (RTA-1100; Nihon Kohden Co. Ltd).
Experimental protocol
After the ERP, action potentials and dV/dt max were measured as baseline recordings. The changes in action potential parameters (action potential duration, APD; resting membrane potential, RMP; dV/dt max ) under the superfusion of Ang II (10 À8 M; Sigma Chemical Co., St Louis, MO, USA) or Ang II plus the AT1 blocker (olmesartan; 10 À7 M) were measured in the two groups: adult SHR Izm s (n¼12) and adult SHR Izm s treated with olmesartan during the previous 8 weeks (n¼12). WKY Izm rats (n¼8) were used as control to determine whether Ang II affects the action potential parameters and AT of the left atrium. Subsequently, the same recordings were performed during RES lasting 60 s. The cycle length of the RES was shortened by 10 ms until a 2:1 conduction block appeared. The cycle length that was 20 ms longer than what was required to induce a 2:1 conduction blocking was defined as the cycle length of RES. The AT and the frequency of the conduction block were measured during RES for 60 s and compared between the experimental groups.
Histological examination and evaluation of fibrous tissue
The left atria were isolated from rat hearts and fixed overnight in buffered neutral formalin. Serial paraffin-embedded tissue sections were stained with hematoxylin-eosin and Masson's trichrome. Microscopic images were saved into a personal computer as picture files. Using Scion Image software (Scion, Frederick, MD, USA), interstitial fibrous tissue stained with blue color was quantitatively assessed by the brightness of its color and expressed as a percentage of the unit area (100Â100 mm 2 ).
Statistical analysis
All measurements are shown as mean ± s.e.m. The statistical significance of intergroup differences in quantitative data was evaluated using Student's t-test (two tailed, unpaired). A value of Po0.05 was considered statistically significant. Angiotensin II-induced conduction blocking N Matsuyama et al RESULTS Table 1 shows the changes in body weight, systolic arterial blood pressure and heart rate, as well as the parameters measured from the LA action potential and the ERP when the preparation was driven with basic cycle length (2 Hz). Data were compared between olmesartan-treated and non-treated preparations. The systolic blood pressure was significantly lower in the olmesartan group, but there were no significant differences in body weight, heart rate, RMP, APD 75 Figure 3a . No significant differences were found among these groups except in AT. The percent changes in AT (DAT) before and after RES (Figure 3b) show that only the DAT measured from untreated SHR Izm s was significantly longer with Ang II compared with that measured from the other groups, which was similar to what is shown in Figure 2 . Furthermore, Ang II induced conduction blocks during RES in untreated SHR Izm s (Figures 4a and b) , and this occurred during the (Figure 4c) . Thus, the conduction block under Ang II perfusion was suppressed by the AT1 receptor blocker, olmesartan. Left atrial histological sections and the percentage of fibrous area in these sections are shown in Figure 5 . In the upper panels, the interstitial spaces in the LA of untreated SHR Izm s (Figure 5a , middle panel, blue color) were larger than those in sections from the other treatments. The percentage fibrous area was significantly larger in untreated than in treated SHR Izm s (Figure 5b ).
DISCUSSION
Reverse remodeling effects of Ang II type 1 receptor blocker A number of studies have used the rapid pacing model for investigating the relationship between atrial reverse remodeling and AF. 3, 7, 8 However, it is not fully understood whether Ang II influences the electrical properties of the remodeled left atrium. In our study, the prolongation of AT during RES, which was observed in SHR Izm s, was not found in SHR Izm s treated with ARB (olmesartan), which may be related to the reverse remodeling action of ARB that prevents reentrant atrial arrhythmias. 9, 10 Chronic AT1 blockade with olmesartan attenuated the increased interstitial fibrous tissue in the left atrium of untreated SHR Izm s. Thus, our data showed that chronic AT1 blockade reduced interstitial fibrosis, but chronic AT1 blockade did not affect the LA action potential characteristics even during RES, except for AT. Therefore, the upregulation of AT1 receptors during RES may play a part in the onset of conduction blocking.
Direct action of Ang II on the remodeled LA When the LA preparations from hypertensive animals were driven by RES, AT through the LA trabecula was lengthened, and conduction blocking appeared with Ang II perfusion (Figures 3 and 4) . This Ang II-induced conduction block was antagonized by the previous administration of ARB (olmesartan) and the superfusion of ARB. The disappearance of Ang II-induced conduction abnormalities is not only because of the reverse LA remodeling action of ARB but also because of the direct action of ARB. This direct action of Ang II has not been previously reported. As the Ang II-induced conduction blocking was generated without a change in the action potential configuration, this phenomenon may be related to a reduction in gap junction conductance. In 1992, De Mello and Altieri 11 used isolated ventricular cell pairs from adult rats and reported that Ang II reduced gap junction conductance by about 55% within 20 s, and that this effect was suppressed by the AT1 blocker losartan. This group suggested that this Ang II-induced action may depend on the activation of protein kinase C. A recent report showed that the AT1 blocker, olmesartan, normalized the prolonged intra-atrial conduction time after 4 weeks of rapid atrial pacing. 7 Kistler et al. 12 investigated the changes in atrial conduction delay and AF inducibility during infusion of Ang II into patients with supraventricular tachycardia who were undergoing curative ablation, and reported no acute effects of Ang II on these electrical parameters. Their data suggest that significant electrophysiological actions of Ang II may appear in some pathological conditions, such as tachycardia, ischemia and hypertension. Other possible data about a relationship between Ang II and atrial conduction in LA tissue have not been reported. 3, 5 Duffy and Wit 13 strongly suggested that the remodeling of gap junctional cell coupling likely contributes to the occurrence of AF. Phosphorylation-dependent changes in gap junctions through AT1 activation seem to be related to Ang II-induced conduction blocking. 14 
Clinical implications and limitations
According to the hypothesis that AF is caused by a single source, AF could be driven by a single or small number of stable, discrete, highfrequency sources in the atrium. 15 The Ang II-induced conduction block during RES observed in our study could promote the maintenance of AF. Therefore, the AT1 blocker olmesartan may be beneficial as a non-antiarrhythmic drug for AF because of its indirect and direct actions. 16 There are some limitations to this study. The site of the conduction block was unclear, as AT includes both conductivity through trabeculae and tissue excitability from contact with the cathode-stimulating electrode. The space constant of mammalian heart tissue, wherein tissue excitability is critical for the onset of myocardial conduction, is known to be between 1 and 2 mm. De Mello and Crespo 17 isolated muscle trabeculae from rat right ventricles and studied the effect of Ang II on tissue excitability. They concluded that Ang II increased ventricular tissue excitability. Therefore, a major cause of Ang IIinduced conduction block could be detrimental conduction through trabeculae. The absence of a clear conduction sequence in whole preparations and also the absence of a detailed localization of interstitial fibrous tissue in trabeculae are additional limitations of this Angiotensin II-induced conduction blocking N Matsuyama et al study. It is difficult to provide an equal flow of a perfusate over an endocardial surface that is covered with intricate fine trabeculae, such as the preparations in this study. Thus, recording only impulse propagation through a thick trabecula in the center of the preparation was considered to be appropriate for this experiment.
